Pasithea shares surge 11.06% intraday after regaining Nasdaq minimum bid price compliance ahead of deadline.

Monday, Dec 15, 2025 2:35 pm ET1min read
KTTA--
Pasithea Therapeutics surged 11.06% intraday after announcing it regained Nasdaq compliance with.

Comments



Add a public comment...
No comments

No comments yet